Effects of Sunitinib, a Protein Tyrosine Kinase Inhibitor, on a Pituitary Lesion in a Patient with Renal Carcinoma
Lanitha Srikugan, Jake Powrie(Guy's and St Thomas' NHS Foundation Trust)
Cited by 1
Related Papers
Blood and Islet Phenotypes Indicate Immunological Heterogeneity in Type 1 Diabetes
|Diabetes|2014|244
Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes
|Science Translational Medicine|2017|215
Peripheral and Islet Interleukin-17 Pathway Activation Characterizes Human Autoimmune Diabetes and Promotes Cytokine-Mediated β-Cell Death
|Diabetes|2011|213
Self‐monitoring in Type 2 diabetes mellitus: a meta‐analysis
|Diabetic Medicine|2000|177
Detection of growth hormone abuse in sport
|Growth Hormone & IGF Research|2007|144